IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Kurimoto, Etsuko ^a   Miyahara, Nobuaki ^a   Kanehiro, Arihiko ^a   Waseda, Koichi ^a   Taniguchi, Akihiko ^a   Ikeda, Genyo ^a   Koga, Hikari ^a   Nishimori, Hisakazu ^a   Tanimoto, Yasushi ^a   Kataoka, Mikio ^a   Iwakura, Yoichiro ^b   Gelfand, Erwin W ^c   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Elastase; Emphysema; IL 17

Indexed keywords

CYTOKINE; ELASTASE; INTERLEUKIN 17; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; NEUTROPHIL RELATED CHEMOKINE; UNCLASSIFIED DRUG; AUTACOID; CHEMOKINE; IL17A PROTEIN, MOUSE; PANCREATIC ELASTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; ELASTASE INDUCED PULMONARY INFLAMMATION; FEMALE; HISTOLOGY; HISTOPATHOLOGY; LUNG COMPLIANCE; LUNG EMPHYSEMA; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NEUTROPHILIA; NONHUMAN; PNEUMONIA; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; MOUSE MUTANT; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; TH17 CELL; TIME;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-17; LUNG; LUNG COMPLIANCE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PANCREATIC ELASTASE; PNEUMONIA; PULMONARY EMPHYSEMA; TH17 CELLS; TIME FACTORS;

MLCS; MLOWN;

EID: 84872360544     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-5     Document Type: Article

References (52)

1. National Heart L, and Blood, Institute National Institutes of Health Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report 2006, National Heart L, and Blood, Institute National Institutes of Health.
2. Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:478-485. 10.1513/pats.200802-014ET, 2645323, 18453359.
3. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653. 10.1056/NEJMoa032158, 15215480.
4. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:1304-1309.
5. Van Der Strate BW, Postma DS, Brandsma CA, Melgert BN, Luinge MA, Geerlings M, Hylkema MN, Van Den Berg A, Timens W, Kerstjens HA. Cigarette smoke-induced emphysema: A role for the B cell?. Am J Respir Crit Care Med 2006, 173:751-758. 10.1164/rccm.200504-594OC, 16399994.
6. Plumb J, Smyth LJ, Adams HR, Vestbo J, Bentley A, Singh SD. Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J 2009, 34:89-94. 10.1183/09031936.00100708, 19196820.
7. Brusselle GG, Demoor T, Bracke KR, Brandsma CA, Timens W. Lymphoid follicles in (very) severe COPD: beneficial or harmful?. Eur Respir J 2009, 34:219-230. 10.1183/09031936.00150208, 19567605.
8. Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component?. Thorax 2003, 58:832-834. 10.1136/thorax.58.10.832, 1746486, 14514931.
9. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007, 13:567-569. 10.1038/nm1583, 17450149.
10. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009, 360:2445-2454. 10.1056/NEJMra0804752, 19494220.
11. Wright JF, Guo Y, Quazi A, Luxenberg DP, Bennett F, Ross JF, Qiu Y, Whitters MJ, Tomkinson KN, Dunussi-Joannopoulos K, et al. Identification of an interleukin 17 F/17A heterodimer in activated human CD4+ T cells. J Biol Chem 2007, 282:13447-13455. 10.1074/jbc.M700499200, 17355969.
12. Padova FD. IL-17A and Th17 cells as therapeutic targets for autoimmune diseases. Th17 Cells: Role in Inflammation and Autoimmune Disease 2009, 227-239.
13. Emamaullee JA, Davis J, Merani S, Toso C, Elliott JF, Thiesen A, Shapiro AM. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009, 58:1302-1311. 10.2337/db08-1113, 2682686, 19289457.
14. Mihara M, Ohsugi Y, Kishimoto T. Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti-interluekin-6 receptor antibody. Biofactors 2009, 35:47-51. 10.1002/biof.9, 19319845.
15. Linden A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur Respir J 2005, 25:159-172. 10.1183/09031936.04.00032904, 15640338.
16. Rahman MS, Yang J, Shan LY, Unruh H, Yang X, Halayko AJ, Gounni AS. IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanism. Clin Immunol 2005, 115:268-276. 10.1016/j.clim.2005.01.014, 15893694.
17. Brereton CF, Sutton CE, Ross PJ, Iwakura Y, Pizza M, Rappuoli R, Lavelle EC, Mills KH. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production. J Immunol 2011, 186:5896-5906. 10.4049/jimmunol.1003789, 21490151.
18. Di Stefano A, Caramori G, Gnemmi I, Contoli M, Vicari C, Capelli A, Magno F, D'Anna SE, Zanini A, Brun P, et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol 2009, 157:316-324. 10.1111/j.1365-2249.2009.03965.x, 2730858, 19604272.
19. Eustace A, Smyth LJ, Mitchell L, Williamson K, Plumb J, Singh D. Identification of cells expressing IL-17A and IL-17 F in the lungs of patients with COPD. Chest 2011, 139:1089-1100. 10.1378/chest.10-0779, 20864612.
20. Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, Rugman P, McCormick M, Woods J, May R, Sleeman MA, et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17 F in asthma and COPD. Chest 2010, 138:1140-1147. 10.1378/chest.09-3058, 2972626, 20538817.
21. Pridgeon C, Bugeon L, Donnelly L, Straschil U, Tudhope SJ, Fenwick P, Lamb JR, Barnes PJ, Dallman MJ. Regulation of IL-17 in chronic inflammation in the human lung. Clin Sci (Lond) 2011, 120:515-524.
22. Hayes JA, Korthy A, Snider GL. The pathology of elastase-induced panacinar emphysema in hamsters. J Pathol 1975, 117:1-14. 10.1002/path.1711170102, 1195057.
23. Kaplan PD, Kuhn C, Pierce JA. The induction of emphysema with elastase. I. The evolution of the lesion and the influence of serum. J Lab Clin Med 1973, 82:349-356.
24. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387. 10.1016/S1074-7613(02)00391-6, 12354389.
25. Inoue K, Takano H, Yanagisawa R, Sakurai M, Abe S, Yoshino S, Yamaki K, Yoshikawa T. Effects of nanoparticles on lung physiology in the presence or absence of antigen. Int J Immunopathol Pharmacol 2007, 20:737-744.
26. Inoue K, Takano H, Ichinose T, Tomura S, Yanagisawa R, Sakurai M, Sumi D, Cho AK, Hiyoshi K, Kumagai Y. Effects of naphthoquinone on airway responsiveness in the presence or absence of antigen in mice. Arch Toxicol 2007, 81:575-581. 10.1007/s00204-007-0186-5, 17318628.
27. Inoue K, Takano H, Yanagisawa R, Sakurai M, Abe S, Yoshino S, Yamaki K, Yoshikawa T. Effects of components derived from diesel exhaust particles on lung physiology related to antigen. Immunopharmacol Immunotoxicol 2007, 29:403-412. 10.1080/08923970701675002, 18075853.
28. Lee JH, Lee DS, Kim EK, Choe KH, Oh YM, Shim TS, Kim SE, Lee YS, Lee SD. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med 2005, 172:987-993. 10.1164/rccm.200501-041OC, 16002570.
29. Fuchimoto Y, Kanehiro A, Miyahara N, Koga H, Ikeda G, Waseda K, Tanimoto Y, Ueha S, Kataoka M, Gelfand EW, Tanimoto M. Requirement for chemokine receptor 5 in the development of allergen-induced airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol 2011, 45:1248-1255. 10.1165/rcmb.2010-0465OC, 3262662, 21757680.
30. Waseda K, Miyahara N, Kanehiro A, Ikeda G, Koga H, Fuchimoto Y, Kurimoto E, Tanimoto Y, Kataoka M, Tanimoto M, Gelfand EW. Blocking the leukotriene B4 receptor 1 inhibits late-phase airway responses in established disease. Am J Respir Cell Mol Biol 2011, 45:851-857. 10.1165/rcmb.2010-0455OC, 3208610, 21421908.
31. Miyahara N, Swanson BJ, Takeda K, Taube C, Miyahara S, Kodama T, Dakhama A, Ott VL, Gelfand EW. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat Med 2004, 10:865-869. 10.1038/nm1081, 15258576.
32. Nishimori H, Maeda Y, Teshima T, Sugiyama H, Kobayashi K, Yamasuji Y, Kadohisa S, Uryu H, Takeuchi K, Tanaka T, et al. Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17. Blood 2012, 119:285-295. 10.1182/blood-2011-01-332478, 22077062.
33. Ishii Y, Itoh K, Morishima Y, Kimura T, Kiwamoto T, Iizuka T, Hegab AE, Hosoya T, Nomura A, Sakamoto T, et al. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol 2005, 175:6968-6975.
34. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, Kheradmand F. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004, 1:e8. 10.1371/journal.pmed.0010008, 523885, 15526056.
35. Hodge G, Nairn J, Holmes M, Reynolds PN, Hodge S. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol 2007, 150:22-29. 10.1111/j.1365-2249.2007.03451.x, 2219288, 17614970.
36. Chang Y, Nadigel J, Boulais N, Bourbeau J, Maltais F, Eidelman DH, Hamid Q. CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res 2011, 12:43. 10.1186/1465-9921-12-43, 3082241, 21477350.
37. Vargas-Rojas MI, Ramirez-Venegas A, Limon-Camacho L, Ochoa L, Hernandez-Zenteno R, Sansores RH. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 2011, 105:1648-1654. 10.1016/j.rmed.2011.05.017, 21763119.
38. Chen K, Pociask DA, McAleer JP, Chan YR, Alcorn JF, Kreindler JL, Keyser MR, Shapiro SD, Houghton AM, Kolls JK, Zheng M. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One 2011, 6:e20333. 10.1371/journal.pone.0020333, 3103542, 21647421.
39. Roussel L, Houle F, Chan C, Yao Y, Berube J, Olivenstein R, Martin JG, Huot J, Hamid Q, Ferri L, Rousseau S. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 2010, 184:4531-4537. 10.4049/jimmunol.0903162, 20228195.
40. Watanabe H, Kawaguchi M, Fujishima S, Ogura M, Matsukura S, Takeuchi H, Ohba M, Sueki H, Kokubu F, Hizawa N, et al. Functional characterization of IL-17 F as a selective neutrophil attractant in psoriasis. J Invest Dermatol 2009, 129:650-656. 10.1038/jid.2008.294, 18830271.
41. Wiehler S, Proud D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2007, 293:L505-515. 10.1152/ajplung.00066.2007, 17545490.
42. Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 2002, 26:748-753.
43. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127. 10.1016/S1074-7613(00)80165-X, 10714678.
44. Burgler S, Ouaked N, Bassin C, Basinski TM, Mantel PY, Siegmund K, Meyer N, Akdis CA, Schmidt-Weber CB. Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol 2009, 123:588-595. 595 e581-587, 10.1016/j.jaci.2008.12.017, 19178935.
45. Shan M, Yuan X, Song LZ, Roberts L, Zarinkamar N, Seryshev A, Zhang Y, Hilsenbeck S, Chang SH, Dong C, et al. Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med 2012, 4:117-119.
46. Saadoun D, Terrier B, Cacoub P. Interleukin-25: key regulator of inflammatory and autoimmune diseases. Curr Pharm Des 2011, 17:3781-3785. 10.2174/138161211798357872, 22103849.
47. Capelli A, Di Stefano A, Gnemmi I, Balbo P, Cerutti CG, Balbi B, Lusuardi M, Donner CF. Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics. Eur Respir J 1999, 14:160-165. 10.1034/j.1399-3003.1999.14a27.x, 10489845.
48. Barcelo B, Pons J, Fuster A, Sauleda J, Noguera A, Ferrer JM, Agusti AG. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2006, 145:474-479. 10.1111/j.1365-2249.2006.03167.x, 1809717, 16907916.
49. Barczyk A, Pierzchala W, Kon OM, Cosio B, Adcock IM, Barnes PJ. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2006, 117:1484-1492. 10.1016/j.jaci.2006.02.013, 16751017.
50. Hoshino T, Kato S, Oka N, Imaoka H, Kinoshita T, Takei S, Kitasato Y, Kawayama T, Imaizumi T, Yamada K, et al. Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am J Respir Crit Care Med 2007, 176:49-62. 10.1164/rccm.200603-316OC, 17400729.
51. Kang MJ, Choi JM, Kim BH, Lee CM, Cho WK, Choe G, Kim DH, Lee CG, Elias JA. IL-18 induces emphysema and airway and vascular remodeling via IFN-gamma, IL-17A, and IL-13. Am J Respir Crit Care Med 2012, 185:1205-1217. 10.1164/rccm.201108-1545OC, 22383501.
52. Harrison OJ, Foley J, Bolognese BJ, Long E, Podolin PL, Walsh PT. Airway infiltration of CD4+ CCR6+ Th17 type cells associated with chronic cigarette smoke induced airspace enlargement. Immunol Lett 2008, 121:13-21. 10.1016/j.imlet.2008.07.011, 18706444.